Published online Dec 20, 2018. doi: 10.5306/wjco.v9.i8.200
Peer-review started: July 12, 2018
First decision: October 8, 2018
Revised: November 7, 2018
Accepted: November 15, 2018
Article in press: November 15, 2018
Published online: December 20, 2018
Processing time: 162 Days and 10.2 Hours
Epithelial-myoepithelial carcinoma (EMC) is a rare, low-grade, malignant tumor that constitutes less than one percent of all salivary gland tumors. To date, only one other case report has described radiation-associated EMC in the English language medical literature.
In this report, we describe the case of a 56-year-old male patient who presented with a neck mass diagnosed as EMC of the left submandibular gland approximately 30 years after mantle field radiation and chemotherapy for Hodgkin lymphoma. Treatment included resection, re-resection with nodal dissection, and adjuvant chemoradiotherapy. This patient was also diagnosed with 4 other secondary malignancies, including stage IV diffuse large B cell lymphoma in the abdomen with subsequent brain metastases, low-grade neuroendocrine carcinoma of the lung, Hurthle cell adenoma, and small B cell lymphoma before the patient expired. This case provides important information regarding the pathology, clinical sequelae, and management of a patient diagnosed with radiation-associated EMC amidst four concurrent malignancies.
Further investigation is needed on the efficacy of adjuvant radiotherapy in EMC, especially atypical EMC.
Core tip: We describe the second known case of radiation-associated epithelial-myoepithelial carcinoma (EMC). This patient received chemotherapy and radiation therapy thirty years prior for Hodgkin lymphoma, and in addition to EMC was also diagnosed with four other malignancies in a span of five years. Because of worrisome histopathologic features atypical for EMC and pathologic stage of this patient, this patient was treated more aggressively with adjuvant chemoradiotherapy. This case provides important information regarding the pathology, clinical sequelae, and management of radiation-associated EMC. Further investigation is needed on the efficacy of adjuvant radiotherapy in EMC, especially atypical EMC.